Ropes & Gray represented Novavax in the transaction. Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, executed the acquisition of Praha…
Novavax’s $167 Million Acquisition Of Praha Vaccines
